Project Engage: Oral PrEP Acceptability
Conditions: Acceptability of Health Care; Adherence, Medication Interventions: Drug: emtricitabine/tenofovir alafenamide; Drug: Emtricitabine / Tenofovir Disoproxil Oral Tablet Sponsors: Eastern Virginia Medical School; CONRAD; FHI 360; United States Agency for International Development (USAID); Gilead Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials